Sat.Jan 20, 2024 - Fri.Jan 26, 2024

article thumbnail

Novel Benzofuran Derivatives Induce Monoamine Release and Substitute for the Discriminative Stimulus Effects of 3,4-Methylenedioxymethamphetamine [Behavioral Pharmacology]

ASPET

3,4-Methylenedioxymethamphetamine (MDMA) has shown efficacy as a medication adjunct for treating post-traumatic stress disorder (PTSD). However, MDMA is also used in non-medical contexts that pose risk for cardiovascular and neurological complications. It is well established that MDMA exerts its effects by stimulating transporter-mediated release of the monoamines, 5-hydroxytryptamine (5-HT), norepinephrine, and dopamine.

Drugs 184
article thumbnail

Scientists design a two-legged robot powered by muscle tissue

Science Daily: Pharmacology News

Compared to robots, human bodies are flexible, capable of fine movements, and can convert energy efficiently into movement. Drawing inspiration from human gait, researchers from Japan crafted a two-legged biohybrid robot by combining muscle tissues and artificial materials. This method allows the robot to walk and pivot.

Research 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A: New approaches are needed to find better cancer drug targets

Broad Institute

Q&A: New approaches are needed to find better cancer drug targets By Allessandra DiCorato January 22, 2024 Breadcrumb Home Q&A: New approaches are needed to find better cancer drug targets Bill Sellers, head of Broad’s Cancer Program, talks about how to discover new classes of genetic dependencies that could move therapies closer to curing cancer patients.

Drugs 128
article thumbnail

What to know after a colon cancer diagnosis

Antidote

Colorectal cancer (often shortened simply to colon cancer) is the fourth-most commonly diagnosed cancer in the United States, and it is estimated that around 150,000 Americans are diagnosed each year. While the average age of diagnosis is 66, young adults are getting diagnosed in higher numbers every year, and researchers are still unsure as to why.

Research 122
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

FDA Warns of Rare Secondary Cancer Risk With CAR-T Therapies

Drugs.com

WEDNESDAY, Jan. 24, 2024 (Healthday News) -- The U.S. Food and Drug Administration has told drugmakers to add a boxed warning to a type of cancer treatment called CAR-T therapy, saying the treatment itself may sometimes cause a secondary.

Therapies 122
article thumbnail

A long-lasting neural probe

Science Daily: Pharmacology News

An interdisciplinary team of researchers has developed a soft implantable device with dozens of sensors that can record single-neuron activity in the brain stably for months.

Research 124

More Trending

article thumbnail

Immuno-oncology innovations redefining cancer treatment in 2024

Drug Target Review

What innovative approaches and technologies are anticipated to reshape immuno-oncology treatments in 2024? Immuno-oncology, notably through checkpoint inhibitors, has significantly reshaped cancer treatment over the past decade. The current shift focuses on enhancing their efficacy by addressing the crucial need for robust T cell responses, an apparent bottleneck for broader impact.

Treatment 122
article thumbnail

How to work with a clinical trial patient recruitment agency

Antidote

Recruiting patients for clinical trials is a common challenge for study sponsors conducting research. For this reason, it is often a wise strategy to work with an agency that specializes in outreach. These agencies excel at helping sponsors achieve their research goals within defined timelines and budgets.

article thumbnail

Robitussin Honey Cough Syrup Recalled Due to Fungal Threat

Drugs.com

THURSDAY, Jan. 25, 2024 -- The maker of Robitussin has recalled eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult cough syrups.The products, which are made by Haleon, may be contaminated with a.

article thumbnail

Achieving sustainable urban growth on a global scale

Science Daily: Pharmacology News

An international group of leading scientists call for an urgent change in the governance of urban expansion as the world's cities continue to grow at unprecedented rates.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Lilly gene therapy finding puts focus on hearing loss treatment pipeline

BioPharma Drive: Drug Pricing

An 11-year-old boy born deaf can hear after receiving Lilly's genetic medicine. Others, including biotechs in China and Regeneron in the U.S., are taking aim at the same drug target.

Therapies 117
article thumbnail

SARS-CoV-2: advancing the production of the ACE2 protein

Drug Target Review

Researchers from Columbia University and the US Department of Energy (DOE)’s Brookhaven National Laboratory have elucidated a method to produce large quantities of the receptor that the SARS-CoV-2 spike protein uses to bind to the surface of human cells. Coronaviruses use the homotrimeric spike glycoprotein, comprising a S1 subunit and S2 subunit in each spike monomer, on the envelope to bind to their cellular receptors.

article thumbnail

Odd Vision Troubles Could Be Early Alzheimer's Sign

Drugs.com

WEDNESDAY, Jan. 24, 2024 -- Strange visual disturbances occur early in about 10% of Alzheimer's cases, and when this happens it almost always signals the impending arrival of the disease, a new study finds.The condition is called posterior cortical.

Disease 116
article thumbnail

Confirmation of ancient lake on Mars builds excitement for Perseverance rover's samples

Science Daily: Pharmacology News

Ground-penetrating radar on board NASA's Mars Perseverance rover has confirmed that the Jezero Crater, formed by an ancient meteor impact just north of the Martian equator, once harbored a vast lake and river delta. Over eons, sediment deposition and erosion within the crater shaped the geologic formations visible on the surface today. The discovery of lake sediments reinforces the hope that traces of life might be found in soil and rock samples collected by Perseverance.

118
118
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

article thumbnail

Karuna, Cerevel might be just the start of psychiatry drug M&A

BioPharma Drive: Drug Pricing

New details of the proposed acquisitions show there were multiple interested buyers, which, according to some analysts, could set the stage for more dealmaking.

Drugs 124
article thumbnail

Deliberate Dysentery

Codon

Introduction The intentional infection of human beings with pathogens under study has been going on for centuries. In 1796, an English physician named Edward Jenner inoculated an 8-year-old boy against smallpox with cowpox lesions he retrieved from the hands of a dairymaid. Today, refined versions of these human challenge studies have become standard practice in testing vaccines for vector-borne diseases (e.g., yellow fever, malaria, and dengue), evaluating new drugs or treatments, and studying

Vaccine 108
article thumbnail

Allergy Alert: What Could New Guidelines on Anaphylaxis Mean for You?

Drugs.com

TUESDAY, Jan. 23, 2024 -- If you or someone close to you suffers from severe allergic reactions, you have probably heard there are new recommendations out that offer guidance on the diagnosis, management and treatment of anaphylaxis.The latest.

Treatment 116
article thumbnail

The underground network: Decoding the dynamics of plant-fungal symbiosis

Science Daily: Pharmacology News

The intricate dance of nature often unfolds in mysterious ways, hidden from the naked eye. At the heart of this enigmatic tango lies a vital partnership: the symbiosis between plants and a type of fungi known as arbuscular mycorrhizal (AM) fungi. New groundbreaking research delves into this partnership, revealing key insights that deepen our understanding of plant-AM fungi interactions and could lead to advances in sustainable agriculture.

Research 116
article thumbnail

Clinical Data Like You´ve Never Seen It Before: Why Spotfire Is the Leading Tool for Clinical Analytics

Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic

article thumbnail

EMA recommends earlier use of Bristol Myers cell therapy for multiple myeloma

BioPharma Drive: Drug Pricing

The opinion would allow Abecma to be prescribed after two standard therapies and is the latest sign of CAR-T’s growing use in earlier cancer treatment.

Therapies 117
article thumbnail

Therapeutic peptide developed for triple-negative breast cancer

Drug Target Review

Researchers from the Cleveland Clinic, led by Dr Ofer Reizes and Dr Justin Lathia, have developed a therapeutic peptide that disrupts the molecular processes behind aggressive cancer cell growth. These findings offer a novel strategy for developing targeted treatments for triple-negative breast cancer, which currently has no approved options. Dr Reizes, the Laura J Fogarty Endowed Chair for Uterine Cancer Research, commented: “It’s devastating that we currently have such limited options to help

Treatment 105
article thumbnail

Depression Can Strike Patients With Heart Failure, But Two Therapies Help

Drugs.com

MONDAY, Jan. 22, 2024 -- Depression affects half of the 6 million Americans who struggle with debilitating heart failure. Now, research shows that two leading modes of treatment -- antidepressants and an approach called behavioral activation.

Therapies 116
article thumbnail

Tiny ant species disrupts lion's hunting behavior

Science Daily: Pharmacology News

Data gathered through years of observation reveal an innocuous-seeming ant is disrupting an ecosystem in East Africa, illustrating the complex web of interactions among ants, trees, lions, zebras and buffaloes.

113
113
article thumbnail

Gilead ADC medicine misses goal in closely watched lung cancer study

BioPharma Drive: Drug Pricing

Trodelvy didn’t outperform chemotherapy in a large study of people with a common lung tumor, a setback that sent company shares down by double digits.

117
117
article thumbnail

#ScienceSaturday: January 20, 2024

KIF1A

#ScienceSaturday posts share exciting scientific developments and educational resources with the KAND community. Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. KAND Resources KAND is a complex disorder, and each patient may experience a wide variety of symptoms that require evaluation by different specialists.

DNA 105
article thumbnail

FDA Issues Another Warning on Tianeptine Products, Which Can Cause Seizures and Death

Drugs.com

THURSDAY, Jan. 25, 2024 -- Reiterating a warning first issued in November, the U.S. Food and Drug Administration is urging Americans to stay away from supplements containing tianeptine, known on the street as "gas station heroin.

article thumbnail

New research challenges hunter-gatherer narrative

Science Daily: Pharmacology News

Analysis of the remains of 24 individuals from the Wilamaya Patjxa and Soro Mik'aya Patjxa burial sites in Peru shows that early human diets in the Andes Mountains were composed of 80 percent plant matter and 20 percent meat.

Research 109
article thumbnail

FDA orders new cancer warnings for CAR-T therapies

BioPharma Drive: Drug Pricing

A black box warning for secondary T cell malignancies should be added to the labeling of all six approved CAR-T therapies, the agency said.

Therapies 122
article thumbnail

Decoding DI in Optimizely CMS 12

Perficient: Drug Development

DI or Dependency Injection is a complex topic, not just in Optimizely CMS, but in general in.net core implementations. Some aspects we get, like the different ways dependencies can be injected and which is better over others, while some leave us scratching our heads. Often times we end up doing a lot of troubleshooting, digging into internal code and finding the right alternatives to DI, to get things to work.

article thumbnail

Putting the Lid Down Won't Cut Germ Spread From a Toilet Flush

Drugs.com

THURSDAY, Jan. 25, 2024 (HealthDay news) -- It’s been said that closing the toilet lid before flushing can prevent the spread of all germs, by keeping any flush-produced mist in the bowl.But a new study refutes that, showing that tiny viral.

105
105
article thumbnail

Coal-based product could replace sand in concrete

Science Daily: Pharmacology News

A new study found that graphene derived from metallurgical coke, a coal-based product, through flash Joule heating could serve not only as a reinforcing additive in cement but also as a replacement for sand in concrete.

article thumbnail

Chewing Gum Reveals Stone Age Diet and Disease

PLOS: DNA Science

We can learn about life, past and present, anywhere we find DNA and determine its sequence. DNA Science has described intriguing sources of environmental DNA, aka eDNA: DNA in Strange Places: Hippo Poop, Zoo Air, and Cave Dirt and A Glimpse of the Ocean’s Twilight Zone Through Environmental DNA. Human remains also harbor bits of DNA that can reveal how people lived long ago.

Disease 98
article thumbnail

Time to Celebrate Sitecore Order Cloud Specialization!

Perficient: Drug Development

This past week was one to celebrate for the Perficient DXP team, as Sitecore awarded us their Order Cloud Specialization. Sitecore takes certification seriously and only recognizes partners with a Specialization if they have proven a deep understanding of the products and a track record of success on relevant projects. The Order Cloud Specialization is the fourth that Perficient has earned in addition to badges for CDP & Personalize , Content Hub and Sitecore XP.

article thumbnail

Heart Disease Still America's Top Killer, Although the Death Rate Has Declined

Drugs.com

WEDNESDAY, Jan. 24, 2024 -- Heart disease remains the United States’ top cause of death, but progress is being made and more lives are being saved, a new report finds.There were 931,578 heart-related deaths in 2021, an increase of less than 3,000.

Disease 105